Used in pharmaceutical synthesis as an intermediate for developing bioactive molecules, particularly in the production of kinase inhibitors and other therapeutic agents targeting inflammatory and oncological diseases. Its structure supports selective binding and improved metabolic stability in drug candidates. Commonly employed in research settings for structure-activity relationship (SAR) studies due to the protected amine group, which allows controlled deprotection and further functionalization during multi-step syntheses.